Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

West Pharmaceutical Services, Inc. WST

Full chart Compare
Set alert

Price alert · WST

All alert types
406.96 USD -0.03 (-0.01%)

Nov 4, 2026, 12:21 PM EST

405.12 Day range 416.46
230.95 52-week range 416.67
YTD
+47.91%
1 year
+41.83%

Financial health

Altman Z-Score

19.23 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B+3 / 5 overall

  • DCF 3
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 3
  • P/E 1
  • P/B 1

Valuation

P/E 40.3×
FY 2016: 43.3×FY 2017: 48.4×FY 2018: 35.0×FY 2019: 46.0×FY 2020: 60.5×FY 2021: 52.7×FY 2022: 29.9×FY 2023: 44.1×FY 2024: 48.5×FY 2025: 40.3×
FY 2016 5y median 44.1× FY 2025
P/S 6.5×
FY 2016: 4.1×FY 2017: 4.6×FY 2018: 4.2×FY 2019: 6.0×FY 2020: 9.8×FY 2021: 12.3×FY 2022: 6.1×FY 2023: 8.9×FY 2024: 8.3×FY 2025: 6.5×
FY 2016 5y median 8.3× FY 2025
P/B 6.3×
FY 2016: 5.6×FY 2017: 5.7×FY 2018: 5.2×FY 2019: 7.1×FY 2020: 11.3×FY 2021: 14.9×FY 2022: 6.5×FY 2023: 9.1×FY 2024: 8.9×FY 2025: 6.3×
FY 2016 5y median 8.9× FY 2025
P/FCF 42.4×
FY 2016: 126×FY 2017: 55.0×FY 2018: 39.4×FY 2019: 46.2×FY 2020: 70.2×FY 2021: 106×FY 2022: 39.8×FY 2023: 63.1×FY 2024: 86.5×FY 2025: 42.4×
FY 2016 5y median 63.1× FY 2025
EV/EBITDA 25.3×
FY 2016: 21.8×FY 2017: 22.2×FY 2018: 20.1×FY 2019: 27.3×FY 2020: 39.8×FY 2021: 39.2×FY 2022: 21.0×FY 2023: 30.3×FY 2024: 31.9×FY 2025: 25.3×
FY 2016 5y median 30.3× FY 2025
EV/Sales 6.4×
FY 2016: 4.1×FY 2017: 4.5×FY 2018: 4.1×FY 2019: 6.0×FY 2020: 9.6×FY 2021: 12.2×FY 2022: 5.9×FY 2023: 8.7×FY 2024: 8.2×FY 2025: 6.4×
FY 2016 5y median 8.2× FY 2025
FCF Yield 2.4%
FY 2016: 0.8%FY 2017: 1.8%FY 2018: 2.5%FY 2019: 2.2%FY 2020: 1.4%FY 2021: 0.9%FY 2022: 2.5%FY 2023: 1.6%FY 2024: 1.2%FY 2025: 2.4%
FY 2016 5y median 1.6% FY 2025

Profitability

Gross Margin 35.9%
FY 2016: 33.2%FY 2017: 32.2%FY 2018: 31.8%FY 2019: 33.0%FY 2020: 35.8%FY 2021: 41.5%FY 2022: 39.5%FY 2023: 38.4%FY 2024: 34.6%FY 2025: 35.9%
FY 2016 5y median 38.4% FY 2025
Operating Margin 20.1%
FY 2016: 14.3%FY 2017: 14.4%FY 2018: 14.8%FY 2019: 16.1%FY 2020: 19.5%FY 2021: 26.8%FY 2022: 26.5%FY 2023: 24.1%FY 2024: 20.6%FY 2025: 20.1%
FY 2016 5y median 24.1% FY 2025
Net Margin 16.1%
FY 2016: 9.5%FY 2017: 9.4%FY 2018: 12.0%FY 2019: 13.1%FY 2020: 16.1%FY 2021: 23.4%FY 2022: 20.3%FY 2023: 20.1%FY 2024: 17.0%FY 2025: 16.1%
FY 2016 5y median 20.1% FY 2025
ROE 15.5%
FY 2016: 12.9%FY 2017: 11.8%FY 2018: 14.8%FY 2019: 15.4%FY 2020: 18.7%FY 2021: 28.3%FY 2022: 21.8%FY 2023: 20.6%FY 2024: 18.4%FY 2025: 15.5%
FY 2016 5y median 20.6% FY 2025
ROIC 13.6%
FY 2016: 10.6%FY 2017: 9.4%FY 2018: 12.5%FY 2019: 11.9%FY 2020: 15.0%FY 2021: 23.5%FY 2022: 20.5%FY 2023: 17.8%FY 2024: 15.7%FY 2025: 13.6%
FY 2016 5y median 17.8% FY 2025
ROA 11.6%
FY 2016: 8.4%FY 2017: 8.1%FY 2018: 13.0%FY 2019: 10.3%FY 2020: 12.4%FY 2021: 20.0%FY 2022: 16.2%FY 2023: 15.5%FY 2024: 13.5%FY 2025: 11.6%
FY 2016 5y median 15.5% FY 2025

Growth (YoY)

Revenue 6.3%
FY 2016: 7.9%FY 2017: 6.0%FY 2018: 7.4%FY 2019: 7.3%FY 2020: 16.4%FY 2021: 31.9%FY 2022: 1.9%FY 2023: 2.3%FY 2024: -2.0%FY 2025: 6.3%
FY 2016 FY 2025
Operating Income 3.8%
FY 2016: 71.4%FY 2017: 6.6%FY 2018: 10.9%FY 2019: 16.6%FY 2020: 41.0%FY 2021: 81.1%FY 2022: 0.6%FY 2023: -6.9%FY 2024: -16.4%FY 2025: 3.8%
FY 2016 FY 2025
EPS (diluted) 1.6%
FY 2016: 46.9%FY 2017: 4.2%FY 2018: 37.7%FY 2019: 17.2%FY 2020: 42.4%FY 2021: 89.7%FY 2022: -10.8%FY 2023: 1.9%FY 2024: -15.1%FY 2025: 1.6%
FY 2016 FY 2025
Free Cash Flow 69.6%
FY 2016: -39.1%FY 2017: 169.3%FY 2018: 38.8%FY 2019: 30.9%FY 2020: 23.8%FY 2021: 10.9%FY 2022: 32.9%FY 2023: -5.7%FY 2024: -33.3%FY 2025: 69.6%
FY 2016 FY 2025

Financial Health

Current Ratio 3.0×
FY 2016: 2.7×FY 2017: 2.7×FY 2018: 3.2×FY 2019: 3.1×FY 2020: 2.7×FY 2021: 2.9×FY 2022: 3.7×FY 2023: 2.9×FY 2024: 2.8×FY 2025: 3.0×
FY 2016 5y median 2.9× FY 2025
Quick Ratio 2.3×
FY 2016: 1.8×FY 2017: 1.9×FY 2018: 2.4×FY 2019: 2.4×FY 2020: 2.1×FY 2021: 2.3×FY 2022: 2.9×FY 2023: 2.2×FY 2024: 2.1×FY 2025: 2.3×
FY 2016 5y median 2.3× FY 2025
Debt / Equity 0.1×
FY 2016: 0.2×FY 2017: 0.2×FY 2018: 0.1×FY 2019: 0.2×FY 2020: 0.2×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA -0.5×
FY 2016: 0.1×FY 2017: -0.1×FY 2018: -0.4×FY 2019: -0.3×FY 2020: -0.6×FY 2021: -0.5×FY 2022: -0.7×FY 2023: -0.6×FY 2024: -0.2×FY 2025: -0.5×
FY 2016 5y median -0.5× FY 2025
Interest Coverage 1029×
FY 2016: 33.7×FY 2017: 32.4×FY 2018: 31.5×FY 2019: 37.1×FY 2020: 49.3×FY 2021: 89.3×FY 2022: 100×FY 2023: 80.8×FY 2024: 205×FY 2025: 1029×
FY 2016 5y median 100× FY 2025

Dividends

Dividend Yield 0.3%
FY 2016: 0.6%FY 2017: 0.5%FY 2018: 0.6%FY 2019: 0.4%FY 2020: 0.2%FY 2021: 0.1%FY 2022: 0.3%FY 2023: 0.2%FY 2024: 0.2%FY 2025: 0.3%
FY 2016 5y median 0.2% FY 2025
Payout Ratio 12.4%
FY 2016: 24.9%FY 2017: 25.9%FY 2018: 20.3%FY 2019: 18.7%FY 2020: 13.9%FY 2021: 7.7%FY 2022: 9.2%FY 2023: 9.6%FY 2024: 12.0%FY 2025: 12.4%
FY 2016 5y median 9.6% FY 2025

Annual · latest fiscal year ends 2025-12-31